Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan

OBJECTIVES: The aim of this study was to examine the cost-effectiveness of branded and authorized generic (AG) celecoxib for chronic pain patients with osteoarthritis (OA), rheumatoid arthritis (RA), and low back pain (LBP), using real-world cost information for loxoprofen and pharmacotherapy for ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Karasawa, Yusuke, Kamae, Isao, Nozawa, Kazutaka, Zeniya, Shigeki, Murata, Tatsunori, Soen, Satoshi, Sakamoto, Choitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259992/
https://www.ncbi.nlm.nih.gov/pubmed/34228745
http://dx.doi.org/10.1371/journal.pone.0253547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259992/
https://www.ncbi.nlm.nih.gov/pubmed/34228745
http://dx.doi.org/10.1371/journal.pone.0253547

Ejemplares similares